MOTUS GI HOLDINGS INC (MOTS)
US62014P5044 - Common Stock
MOTS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 193 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of MOTS have multiple concerns. While showing a medium growth rate, MOTS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year MOTS has reported negative net income.
In the past year MOTS has reported a negative cash flow from operations.
In the past 5 years MOTS always reported negative net income.
MOTS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -178.25%, MOTS is doing worse than 92.31% of the companies in the same industry.
The Return On Equity of MOTS (-479.16%) is worse than 88.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -178.25% | ||
| ROE | -479.16% | ||
| ROIC | N/A |
ROA(3y)-126.68%
ROA(5y)-106.33%
ROE(3y)-454.56%
ROE(5y)-332.05%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for MOTS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
MOTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MOTS has more shares outstanding
MOTS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MOTS has been reduced compared to a year ago.
2.2 Solvency
MOTS has an Altman-Z score of -34.76. This is a bad value and indicates that MOTS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -34.76, MOTS is doing worse than 91.79% of the companies in the same industry.
A Debt/Equity ratio of 0.46 indicates that MOTS is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.46, MOTS is doing worse than 62.05% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -34.76 |
ROIC/WACCN/A
WACC10.68%
2.3 Liquidity
A Current Ratio of 1.76 indicates that MOTS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.76, MOTS is doing worse than 77.44% of the companies in the same industry.
MOTS has a Quick Ratio of 1.61. This is a normal value and indicates that MOTS is financially healthy and should not expect problems in meeting its short term obligations.
MOTS's Quick ratio of 1.61 is on the low side compared to the rest of the industry. MOTS is outperformed by 67.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.61 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 68.99% over the past year.
Looking at the last year, MOTS shows a very negative growth in Revenue. The Revenue has decreased by -46.00% in the last year.
MOTS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 51.48% yearly.
EPS 1Y (TTM)68.99%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q62.19%
Revenue 1Y (TTM)-46%
Revenue growth 3Y47.21%
Revenue growth 5Y51.48%
Revenue growth Q2Q-41.82%
3.2 Future
The Earnings Per Share is expected to grow by 25.56% on average over the next years. This is a very strong growth
Based on estimates for the next years, MOTS will show a very strong growth in Revenue. The Revenue will grow by 206.79% on average per year.
EPS Next Y58.34%
EPS Next 2Y40.28%
EPS Next 3Y25.56%
EPS Next 5YN/A
Revenue Next Year337.5%
Revenue Next 2Y301.56%
Revenue Next 3Y206.79%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MOTS. In the last year negative earnings were reported.
Also next year MOTS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as MOTS's earnings are expected to grow with 25.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.28%
EPS Next 3Y25.56%
5. Dividend
5.1 Amount
No dividends for MOTS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MOTUS GI HOLDINGS INC
NASDAQ:MOTS (4/15/2024, 7:19:47 PM)
After market: 0.1512 -0.02 (-12.85%)0.1735
-0.09 (-34.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap872.70K
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -178.25% | ||
| ROE | -479.16% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.46 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.61 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)68.99%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y58.34%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-46%
Revenue growth 3Y47.21%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y